Breaking News Instant updates and real-time market news.

ASLN

Aslan Pharmaceuticals

$2.81

-0.15 (-5.07%)

05:26
08/13/19
08/13
05:26
08/13/19
05:26

Aslan Pharmaceuticals reports Q2 EPS (5c), consensus (20c)

Dr Carl Firth, CEO, ASLAN Pharmaceuticals, said: "ASLAN made significant progress through the second quarter of this year, highlighted by our agreement with K-MASTER investigating varlitinib in metastatic gastric cancer patients, updated results from the ongoing clinical program studying ASLAN003 in AML, as well as results from our ASLAN004 single ascending dose study supporting differentiation versus other IL4/IL13 receptor inhibitors. Based on this exciting new data, we amended the agreement with CSL Limited to include full global rights to develop, manufacture, and commercialise this first in class therapeutic antibody for atopic dermatitis and other indications. Looking forward to the remainder of the year, we await topline data from our pivotal TreeTopp trial as second line treatment for biliary tract cancer, in the fourth quarter."

ASLN Aslan Pharmaceuticals
$2.81

-0.15 (-5.07%)

01/14/19
HCWC
01/14/19
NO CHANGE
Target $8.5
HCWC
Buy
Aslan Pharmaceuticals price target lowered to $8.50 from $12 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju lowered his price target for Aslan Pharmaceuticals to $8.50 after varlitinib data in first-line gastric cancer didn't show statistical significance. The analyst, however, reiterates a Buy rating on the shares.
01/15/19
PIPR
01/15/19
NO CHANGE
Target $7
PIPR
Overweight
Aslan achieved 'impressive' overall response rate in BTC, says Piper Jaffray
Aslan Pharmaceuticals' varlitinib added to gemcitabine and cisplatine achieved an "impressive" overall response rate of 43.8% and disease control rate of 93.8% in the Phase Ib/II study in first-line biliary tract cancer, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. Varlitinib was also well tolerated with the most common adverse events decreases in platelet and neutrophil counts, adds the analyst. The data presented last night increase his confidence in the fully-enrolled Phase III TreeTopp trial of varlitinib in second line biliary tract cancer with top-line data in the second half of 2019. He reiterates an Overweight rating on Aslan Pharmaceuticals with a $7 price target.
01/30/19
PIPR
01/30/19
NO CHANGE
Target $7
PIPR
Overweight
Piper Jaffray reiterates Overweight rating on Aslan after restructuring news
After Aslan Pharmaceuticals announced it is conducting a corporate restructuring that will cut headcount by 30% and operating costs by 50%, Piper Jaffray analyst Edward Tenthoff noted the restructuring does not impact development of wholly-owned varlitinib in biliary tract cancer, ASLAN003 in acute myeloid leukemia and ASLAN004 in atopic dermatitis. Tenthoff, who said the primary driver for varlitinib remains Phase 3 TreeTopp trial data in the second half of 2019, reiterates an Overweight rating and $7 price target on Aslan shares.
04/01/19
PIPR
04/01/19
NO CHANGE
Target $7
PIPR
Overweight
Aslan data show comparable activity to Dupixent, says Piper Jaffray
Aslan Pharmaceuticals reported preliminary Phase I single-ascending dose data on intravenous ASLAN004 demonstrating the IL13 receptor antibody to be safe and well tolerated in healthy volunteers with no discontinuations due to adverse events, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. ASLAN004 caused complete inhibition of phosphorylation of STAT6 within one hour lasting for greater than 29 days, adds the analyst. He believes these results present the opportunity for once-monthly dosing of ASLAN004 with comparable activity to Regeneron's (REGN) Dupixent. Tenthoff reiterates an Overweight rating on Aslan Pharmaceuticals with a $7 price target.

TODAY'S FREE FLY STORIES

BIDU

Baidu

$104.30

7.65 (7.92%)

14:49
08/19/19
08/19
14:49
08/19/19
14:49
Options
Baidu options imply 14.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 04

    Sep

AVYA

Avaya

$12.27

-0.25 (-2.00%)

14:46
08/19/19
08/19
14:46
08/19/19
14:46
Periodicals
Avaya said to get bid from Mitel, Bloomberg says »

Avaya is weighing a bid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

TXG

10x Genomics

$0.00

(0.00%)

14:46
08/19/19
08/19
14:46
08/19/19
14:46
Syndicate
10x Genomics files for IPO, to list on Nasdaq under symbol 'TXG' »

10x Genomics filed an S-1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.05

0.085 (0.95%)

14:45
08/19/19
08/19
14:45
08/19/19
14:45
Periodicals
Ford to build two new midsize EV crossovers, Automotive News reports »

Ford Motor plans to build…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

HIIQ

Health Insurance Innovations

$17.42

-0.11 (-0.63%)

14:45
08/19/19
08/19
14:45
08/19/19
14:45
Options
Health Insurance Innovations call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

LAZ

Lazard

$34.27

1.14 (3.44%)

14:43
08/19/19
08/19
14:43
08/19/19
14:43
Periodicals
Lazard seen as top contender for role in Saudi Aramco IPO, Bloomberg says »

Lazard's success on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$41.98

4.93 (13.31%)

14:39
08/19/19
08/19
14:39
08/19/19
14:39
Upgrade
Weibo rating change  »

Weibo upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

FB

Facebook

$186.22

2.8 (1.53%)

14:33
08/19/19
08/19
14:33
08/19/19
14:33
Hot Stocks
Facebook says removing 'coordinated inauthentic behavior' from China »

Facebook's Nathaniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

GOOG

Alphabet

$1,201.56

24.62 (2.09%)

, GOOGL

Alphabet Class A

$1,203.66

24.97 (2.12%)

14:32
08/19/19
08/19
14:32
08/19/19
14:32
Periodicals
'Cyberpunk 2077' coming to Google Stadia, Verge reports »

Google (GOOG) announced…

GOOG

Alphabet

$1,201.56

24.62 (2.09%)

GOOGL

Alphabet Class A

$1,203.66

24.97 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

TRP

TC Pipeline

$48.70

0.3 (0.62%)

, SRE

Sempra Energy

$139.87

0.93 (0.67%)

14:31
08/19/19
08/19
14:31
08/19/19
14:31
Periodicals
Mexico near pact with pipeline builders, Reuters reports »

Mexico is close to…

TRP

TC Pipeline

$48.70

0.3 (0.62%)

SRE

Sempra Energy

$139.87

0.93 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$42.03

4.98 (13.44%)

14:30
08/19/19
08/19
14:30
08/19/19
14:30
Upgrade
Weibo rating change  »

Weibo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

NBRV

Nabriva Therapeutics

$2.13

-0.14 (-6.17%)

14:28
08/19/19
08/19
14:28
08/19/19
14:28
Hot Stocks
Breaking Hot Stocks news story on Nabriva Therapeutics »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 09

    Sep

LAZ

Lazard

$33.90

0.77 (2.32%)

14:24
08/19/19
08/19
14:24
08/19/19
14:24
Periodicals
Breaking Periodicals news story on Lazard »

Lazard seen as top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFGP

Ledyard Financial Group

$0.00

(0.00%)

14:21
08/19/19
08/19
14:21
08/19/19
14:21
Hot Stocks
Ledyard Financial Group announces 120K share repurchase plan »

Ledyard Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$41.69

1.11 (2.74%)

14:19
08/19/19
08/19
14:19
08/19/19
14:19
Hot Stocks
Twitter says will no longer accept advertising from state-controlled news media »

In a blog post, Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 20

    Aug

  • 24

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
08/19/19
08/19
14:17
08/19/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
08/19/19
08/19
14:16
08/19/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$48.17

2.66 (5.84%)

, TJX

TJX

$51.87

0.45 (0.88%)

14:11
08/19/19
08/19
14:11
08/19/19
14:11
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KSS

Kohl's

$48.17

2.66 (5.84%)

TJX

TJX

$51.87

0.45 (0.88%)

MDT

Medtronic

$103.90

1.17 (1.14%)

HD

Home Depot

$208.01

4.37 (2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

14:10
08/19/19
08/19
14:10
08/19/19
14:10
General news
Treasury Action: Treasuries remain heavy »

Treasury Action:…

CHE

Chemed

$434.70

4.53 (1.05%)

14:09
08/19/19
08/19
14:09
08/19/19
14:09
Hot Stocks
Chemed VP Michael Witzeman sells almost $2M in company shares »

Chemed VP Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
08/19/19
08/19
14:05
08/19/19
14:05
General news
Fed's Rosengren said he believes monetary and fiscal policy are already accommodative »

Fed's Rosengren said…

AAPL

Apple

$211.93

5.49 (2.66%)

, MSFT

Microsoft

$138.27

2.14 (1.57%)

14:02
08/19/19
08/19
14:02
08/19/19
14:02
Periodicals
Microsoft hires former head of Apple's Siri efforts, The Information says »

Microsoft (MSFT) has…

AAPL

Apple

$211.93

5.49 (2.66%)

MSFT

Microsoft

$138.27

2.14 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

RRR

Red Rock Resorts

$19.46

0.75 (4.01%)

, AES

AES Corp.

$15.46

0.25 (1.64%)

13:44
08/19/19
08/19
13:44
08/19/19
13:44
On The Fly
Fly Insider: Red Rock Resorts, Walgreen's among weeks notable insider trades »

Welcome to "Fly Insider,"…

RRR

Red Rock Resorts

$19.46

0.75 (4.01%)

AES

AES Corp.

$15.46

0.25 (1.64%)

GE

General Electric

$8.66

-0.13 (-1.48%)

MD

Mednax

$22.28

0.62 (2.86%)

CFR

Cullen/Frost

$85.74

0.95 (1.12%)

TWNK

Hostess Brands

$14.01

0.06 (0.43%)

WEN

Wendy's

$20.44

0.5 (2.51%)

PSA

Public Storage

$260.91

2.23 (0.86%)

AYX

Alteryx

$133.18

-0.57 (-0.43%)

WBA

Walgreens Boots Alliance

$51.40

1.3975 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 03

    Sep

  • 04

    Sep

  • 09

    Sep

  • 23

    Sep

  • 02

    Oct

  • 30

    Oct

  • 13

    Nov

GIG

GigCapital

$10.30

(0.00%)

13:43
08/19/19
08/19
13:43
08/19/19
13:43
Hot Stocks
GigCapital announces launching of de-SPACing efforts of Kaleyra combination »

GigCapital announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.42

-0.1 (-0.80%)

13:36
08/19/19
08/19
13:36
08/19/19
13:36
Hot Stocks
Breaking Hot Stocks news story on Avaya »

Avaya Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.